Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Human Immunodeficiency Virus 1”

2,454 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 2,454 results

Very early researchNot Yet RecruitingNCT07281404
What this trial is testing

FIH Lead-in Study of YASO GEL Followed by a Phase 1 Randomized, Double-blind Study to Assess Safety and Pharmacokinetics of YASO GEL

Who this might be right for
Early-phase Safety and PK Study of a Vaginal Gel
Yaso Therapeutics Corporation 72
Post-approval studies (Phase 4)Study completedNCT03098121
What this trial is testing

Efficacy and Tolerability of Grazoprevir and Elbasvir in Patients With Chronic Genotype 1 HCV and HIV Co-infection

Who this might be right for
Chronic Hepatitis C
Taoyuan General Hospital 40
Early research (Phase 1)Study completedNCT02217904
What this trial is testing

Islatravir (MK-8591) in Anti-Retroviral Therapy-Naive, Human Immunodeficiency Virus-1 Infected Participants (MK-8591-003)

Who this might be right for
HIV-1
Merck Sharp & Dohme LLC 30
Early research (Phase 1)Study completedNCT00063804
What this trial is testing

Safety of AMD070 When Administered Alone or Boosted With Low-Dose Ritonavir in HIV Uninfected Men

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 44
Testing effectiveness (Phase 2)Study completedNCT00002235
What this trial is testing

A Study on the Safety and Effectiveness of Twice-Daily Nelfinavir Plus Twice-Daily Indinavir Plus Efavirenz in HIV-Positive Patients Who Have Never Taken Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) or Protease Inhibitors

Who this might be right for
HIV Infections
Merck Sharp & Dohme LLC 6
Testing effectiveness (Phase 2)Study completedNCT05004038
What this trial is testing

BCG Vaccination Effect on Latent Reservoir Size in Treated HIV-1 Infection:

Who this might be right for
HIV-1-infection
University of Zurich 60
Testing effectiveness (Phase 2)Study completedNCT00654147
What this trial is testing

Raltegravir + Lopinavir/Ritonavir or Emtricitabine/Tenofovir for HIV Treatment Naive Subjects

Who this might be right for
HIV Infections
Margaret A. Fischl, M.D. 44
Early research (Phase 1)Study completedNCT00002363
What this trial is testing

The Safety and Effectiveness of SPC3 in HIV-1 Infected Patients

Who this might be right for
HIV Infections
Columbia Research Laboratories 20
Testing effectiveness (Phase 2)Study completedNCT00848211
What this trial is testing

Clinical Study of TUTI-16 in Asymptomatic HIV-1 Infected Subjects

Who this might be right for
HIV Infections
Thymon, LLC 24
Large-scale testing (Phase 3)Study completedNCT05306704
What this trial is testing

High-Dose Vitamin D3 Supplementation in the Treatment of Human Immune Deficiency Virus Patients Trial

Who this might be right for
HIV-1-infectionHypovitaminosis D
University of the Punjab 95
Not applicableLooking for participantsNCT05602376
What this trial is testing

Improving HIV Testing, Linkage, and Retention in Care for Men Through U=U Messaging

Who this might be right for
HIV InfectionsMenTreatment Adherence
Desmond Tutu HIV Foundation 3,642
Testing effectiveness (Phase 2)Ended earlyNCT02239835
What this trial is testing

Tipranavir and Ritonavir vs. Saquinavir and Ritonavir Used With Two Nucleoside Reverse Transcriptase Inhibitors in Single Protease Inhibitor-experienced HIV-1 Patients

Who this might be right for
HIV Infections
Boehringer Ingelheim 79
Post-approval studies (Phase 4)Study completedNCT03087890
What this trial is testing

Impact of Cotrimoxazole Use in Immunocompetent HIV Patients on Carriage of Antimicrobial Resistant Bacteria

Who this might be right for
HIV-1-infectionPneumocystis PneumoniaOpportunistic Infections+2 more
University of Bergen 537
Post-approval studies (Phase 4)UnknownNCT03774108
What this trial is testing

Metformin and Systemic Inflammation in HIV

Who this might be right for
PreDiabetesHIV-1-infection
Hospital Civil de Guadalajara 40
Early research (Phase 1)Study completedNCT00000782
What this trial is testing

A Phase I/II Study of Delayed-Type Hypersensitivity (DTH) Reactions to Intradermal HIV Envelope Antigen

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 50
Early research (Phase 1)Study completedNCT00000774
What this trial is testing

A Phase I Study to Evaluate the Safety and Immunogenicity of Recombinant HIV-1 Envelope Antigen in Children Born to HIV-Infected Mothers

Who this might be right for
HIV InfectionsHIV Seronegativity
National Institute of Allergy and Infectious Diseases (NIAID) 156
Testing effectiveness (Phase 2)Study completedNCT00002171
What this trial is testing

Viracept in HIV-Positive Women

Who this might be right for
HIV Infections
Agouron Pharmaceuticals
Not applicableUnknownNCT04858243
What this trial is testing

Engaging Men Through HIV Self-Testing With Differentiated Care to Improve ART Initiation and Viral Suppression Among Men in Malawi

Who this might be right for
Hiv
University of California, Los Angeles 930
Early research (Phase 1)Looking for participantsNCT06724640
What this trial is testing

Assess the Safety, Tolerability, and Pharmacokinetics of VH4011499 Compared to Placebo in Adults Without HIV

Who this might be right for
HIV Infections
ViiV Healthcare 168
Not applicableStudy completedNCT01508559
What this trial is testing

Men Who Have Sex With Men (MSM) Neurocog 1&2 Study

Who this might be right for
HIV Related Neurocognitive Impairment
St Stephens Aids Trust 237
Next Page